![](/img/cover-not-exists.png)
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Armstrong, Andrew J, Halabi, Susan, Eisen, Tim, Broderick, Samuel, Stadler, Walter M, Jones, Robert J, Garcia, Jorge A, Vaishampayan, Ulka N, Picus, Joel, Hawkins, Robert E, Hainsworth, John D, KollmaLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00515-X
Date:
January, 2016
File:
PDF, 551 KB
english, 2016